| Title |
Levodopa for the treatment of restless legs syndrome
|
|---|---|
| Published in |
Cochrane database of systematic reviews, February 2011
|
| DOI | 10.1002/14651858.cd005504.pub2 |
| Pubmed ID | |
| Authors |
Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann, Magdolna Hornyak |
| Abstract |
Levodopa plus dopamine decarboxylase inhibitor is a common treatment for restless legs syndrome (RLS). |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 95 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 20 | 21% |
| Student > Bachelor | 12 | 13% |
| Researcher | 8 | 8% |
| Student > Postgraduate | 6 | 6% |
| Student > Doctoral Student | 5 | 5% |
| Other | 13 | 14% |
| Unknown | 31 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 32 | 34% |
| Nursing and Health Professions | 9 | 9% |
| Psychology | 6 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Social Sciences | 3 | 3% |
| Other | 7 | 7% |
| Unknown | 35 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 January 2024.
All research outputs
#7,387,249
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#8,415
of 11,499 outputs
Outputs of similar age
#54,087
of 205,724 outputs
Outputs of similar age from Cochrane database of systematic reviews
#59
of 123 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 205,724 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.